pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Jun 2·1 min read
save

Obesity care startup Ilant Health secures $15M Series A funding

Jun 2, 2026·read at Endpoints ↗DealPositive

Ilant Health, a startup focused on obesity care, announced a $15 million Series A financing round.

The capital will be used to broaden its personalized treatment platform, which leverages virtual care to address obesity.

The raise places Ilant among a growing number of digital health companies targeting employers and health insurers seeking weight management solutions.

The funding round underscores investor interest in obesity‑focused technologies, though the company did not disclose the investors involved.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “Obesity care startup Ilant Health raises $15M”

read at Endpoints ↗
87 words · retrieved Jun 2
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

drugs
Obesity5
topics
Obesity5

related stories

  • Apr 30STAT+: FDA wants to exclude weight loss drugs from a compounding listSTAT
  • Apr 30Smog from wildfires increasingly harmful, data showSTAT
  • Apr 30Updated: Early sales of Lilly’s obesity pill appear to trail Novo’sEndpoints
  • Apr 30STAT+: New obesity tool aims to predict risk of 18 serious complicationsSTAT
  • Apr 29STAT+: A patent win for Pfizer and BridgeBioSTAT